MNTX yields 34.48% · JNJ yields 2.13%● Live data
📍 MNTX pulled ahead of the other in Year 1
Combined, MNTX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNTX + JNJ for your $10,000?
Manitex International, Inc. provides engineered lifting solutions in the United States, Italy, Canada, France, Chile, and internationally. It designs, manufactures, and distributes products that are used in various industries. The company also offers boom trucks, truck cranes, aerial platforms, and sign cranes products primarily for use in industrial projects, energy exploration, and infrastructure development comprising roads, bridges, and commercial construction. In addition, it manufactures and sells rough terrain cranes and material handling products for construction, municipality, and railroad industries; and truck mounted hydraulic knuckle boom cranes. The company provides its products under the Manitex, PM, MAC, PM-Tadano, Oil & Steel, Badger, and Valla brands. It also sells its products through dealers and rental distribution channel. The company was formerly known as Veri-Tek International, Corp. and changed its name to Manitex International, Inc. in May 2008. Manitex International, Inc. was founded in 1993 and is headquartered in Bridgeview, Illinois.
Full MNTX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.